Bicalutamide Chemical Structure (7cd5fd99 Ea7f 432d Aa05 8c0ab4fffb75 01)
Bicalutamide
Product Images NDC 60505-2642
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Bicalutamide (NDC 60505-2642). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Bicalutamide Figure 1 (7cd5fd99 Ea7f 432d Aa05 8c0ab4fffb75 02)
This appears to be a chart showing the proportion of individuals who did not experience progression over time when treated with Bicalutamide plus LHRH-A or Flutamide plus LHRH-A. The x-axis represents the number of days, ranging from 365 to 1825, and the y-axis represents the proportion of individuals who did not experience progression.*
Bicalutamide Figure 2 (7cd5fd99 Ea7f 432d Aa05 8c0ab4fffb75 03)
Bicalutamide 50 mg Label (7cd5fd99 Ea7f 432d Aa05 8c0ab4fffb75 04)
This is a medication called Bicalutamide USP 50mg, contained in tablets. It is manufactured by Infas Pharmaceticals Limited in India and distributed by Apotex Corp in Florida. The usual dosage of this medication can be found in the accompanying prescribing information, and it should be stored at controlled room temperature between 20 to 25°C (68 to 77°F). There is a warning to keep it out of reach of children. The package contains 30 tablets, and the pharmacist should dispense with a patient package insert. There is an expiration date, but it is not specified in this text.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
